EcoDrugPlus

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSPREG00000005553
Gene Symbol: F3
3 Cross references
199 Possible Orthologues:

Coagulation Factor Vii-Like

Ensembl ID : ENSPREG00000022540
Gene Symbol: LOC103457832
3 Cross references
78 Possible Orthologues:

Coagulation Factor X-Like

Ensembl ID : ENSPREG00000022559
Gene Symbol: LOC103457956
3 Cross references
238 Possible Orthologues:

Coagulation Factor Xi-Like

Ensembl ID : ENSPREG00000019123
Gene Symbol: LOC103472119
2 Cross references
204 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSPREG00000010923
Gene Symbol: CCDC6
3 Cross references
207 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSPREG00000007228
Gene Symbol: LOC103461519
2 Cross references
280 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSPREG00000003659
Gene Symbol: CSF1R
2 Cross references
204 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSPREG00000002893
Gene Symbol: LOC103471278
3 Cross references
63 Possible Orthologues:

Complement C5

Ensembl ID : ENSPREG00000003252
Gene Symbol: C5
2 Cross references
216 Possible Orthologues:

Corticotropin-Releasing Factor Receptor 1-Like

Ensembl ID : ENSPREG00000008701
Gene Symbol: LOC103481615
2 Cross references
207 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSPREG00000001946
Gene Symbol: CCND1
3 Cross references
231 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSPREG00000007000
Gene Symbol: CDK1
3 Cross references
247 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).